Minireview: Spatial programming of g protein-coupled receptor activity: Decoding signaling in health and disease

Molecular Endocrinology

Volumn 29, Issue 8, 2015, Pages 1095-1106

  West, Camilla ^a   Hanyaloglu, Aylin C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; BETA ARRESTIN 2; CALCIUM CHANNEL L TYPE; CANNABINOID 1 RECEPTOR; CAVEOLIN; CHEMOKINE RECEPTOR CCR5; CLATHRIN HEAVY CHAIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; GLUCOCORTICOID RECEPTOR; GONADORELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; INSULIN; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN ZO1; PURINERGIC P2Y12 RECEPTOR; RGS PROTEIN; SCAFFOLD PROTEIN; SEROTONIN 1A RECEPTOR; SORTING NEXIN; CLATHRIN; RETINA S ANTIGEN;

ACROSOME REACTION; CAVEOLA; CELL COMMUNICATION; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CELL PROLIFERATION; COATED VESICLE; DESENSITIZATION; ENDOCRINE DISEASE; ENDOCYTOSIS; ENDOSOME; HUMAN; HYPERINSULINEMIA; INFLAMMATORY DISEASE; INTERNALIZATION; LIPID RAFT; NONHUMAN; OOCYTE MATURATION; OVARY POLYCYSTIC DISEASE; PLEIOTROPY; PREGNANCY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPRODUCTION; REVIEW; SERTOLI CELL; SIGNAL TRANSDUCTION; SPERMATOCYTE; SUBFERTILITY; ANIMAL; CHEMISTRY; FEMALE; METABOLISM; MOUSE; PROTEIN TRANSPORT;

ANIMALS; ARRESTINS; CAVEOLAE; CELL MEMBRANE; CLATHRIN; ENDOCYTOSIS; ENDOSOMES; FEMALE; HUMANS; MEMBRANE MICRODOMAINS; MICE; PREGNANCY; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84938348387     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/ME.2015-1065     Document Type: Review

References (126)

1. Scita G, Di Fiore PP. The endocytic matrix. Nature. 2010;463: 464-473.
2. Durieux AC, Prudhon B, Guicheney P, Bitoun M. Dynamin 2 and human diseases. J Mol Med. 2010;88:339-350.
3. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol. 2008;48:537-568.
4. McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2011;12:517-533.
5. Rao Y, Rückert C, Saenger W, Haucke V. The early steps of en-docytosis: from cargo selection to membrane deformation. Eur J Cell Biol. 2012;91:226-233.
6. Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012;13:75-88.
7. Reiter E, Lefkowitz RJ. GRKs and β arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab. 2006;17:159-165.
8. Shenoy SK, Lefkowitz RJ. Multifaceted roles of β arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J. 2003;375:503-515.
9. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. β arrestins and cell signaling. Annu Rev Physiol. 2007;69:483-510.
10. Kang DS, Tian X, Benovic JL. Role of β arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol. 2014;27:63-71.
11. Kang DS, Tian X, Benovic JL. β Arrestins and G protein-coupled receptor trafficking. Methods Enzymol. 2013;521:91-108.
12. Cao TT, Mays RW, von Zastrow M. Regulated endocytosis of G-protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits. J Biol Chem. 1998; 273:24592-24602
13. Lakadamyali M, Rust MJ, Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell. 2006;124:997-1009.
14. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic. 2006;7:1420-1431.
15. Puthenveedu MA, von Zastrow M. Cargo regulates clathrin-coated pit dynamics. Cell. 2006;127:113-124.
16. McArdle CA, Franklin J, Green L, Hislop JN. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol. 2002;173:1-11.
17. Vrecl M, Heding A, Hanyaloglu A, Taylor PL, Eidne KA. Internalization kinetics of the gonadotropin-releasing hormone (GnRH) receptor. Pflugers Arch. 2000;439:R19-R20.
18. Soohoo AL, Puthenveedu MA. Divergent modes for cargo-mediated control of clathrin-coated pit dynamics. Mol Biol Cell. 2013; 24:1725-1734, S1721-S1712
19. Flores-Otero J, Ahn KH, Delgado-Peraza F, Mackie K, Kendall DA, Yudowski GA. Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1. Nat Commun. 2014;5:4589
20. Farkas I, Kalló I, Deli L, et al. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology. 2010;151:5818-5829.
21. Pal K, Mathur M, Kumar P, DeFea K. Divergent β arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini. J Biol Chem. 2013;288:3265-3274.
22. Nobles KN, Xiao K, Ahn S, et al. Distinct phosphorylation sites on the (2)-adrenergic receptor establish a barcode that encodes differential functions of β arrestin. Sci Signal. 2011;4: ra51.
23. Lampe M, Pierre F, Al-Sabah S, Krasel C, Merrifield CJ. Dual single-scission event analysis of constitutive transferrin receptor (TfR) endocytosis and ligand-triggered ÷2-adrenergic receptor (β2AR) or Mu-opioid receptor (MOR) endocytosis. Mol Biol Cell. 2014;25:3070-3080
24. Grove J, Metcalf DJ, Knight AE, et al. Flat clathrin lattices: stable features of the plasma membrane. Mol Biol Cell. 2014;25:3581-3594.
25. Dominguez F, Galan A, Martin JJ, Remohi J, Pellicer A, Simón C. Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. Mol Hum Reprod. 2003;9:189-198.
26. Isobe T, Minoura H, Tanaka K, Shibahara T, Hayashi N, Toyoda N. The effect of RANTES on human sperm chemotaxis. Hum Reprod. 2002;17:1441-1446.
27. Barbonetti A, Vassallo MR, Antonangelo C, et al. RANTES and human sperm fertilizing ability: effect on acrosome reaction and sperm/oocyte fusion. Mol Hum Reprod. 2008;14:387-391.
28. Vogl AW, Du M, Wang XY, Young JS. Novel clathrin/actin-based endocytic machinery associated with junction turnover in the seminiferous epithelium. Semin Cell Dev Biol. 2014;30:55-64.
29. Adeoya-Osiguwa SA, Fraser LR. Cathine, an amphetamine-related compound, acts on mammalian spermatozoa via ÷1-and 2A-adrenergic receptors in a capacitation state-dependent man-ner. Hum Reprod. 2007;22:756-765.
30. Etkovitz N, Tirosh Y, Chazan R, et al. Bovine sperm acrosome reaction induced by G-protein-coupled receptor agonists is mediated by epidermal growth factor receptor transactivation. Dev Biol. 2009;334:447-457.
31. Shihan M, Bulldan A, Scheiner-Bobis G. Non-classical testosterone signaling is mediated by a G-protein-coupled receptor interacting with Gn 11. Biochim Biophys Acta. 2014;1843:1172-1181.
32. Luttrell LM, Lefkowitz RJ. The role of β arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002;115:455-465.
33. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by β arrestins. Science. 2005;308:512-517.
34. Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev. 2010;62:305-330.
35. Mukherjee S, Gurevich VV, Jones JC, et al. The ADP ribosylation factor nucleotide exchange factor ARNO promotes β arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc Natl Acad Sci USA. 2000;97:5901-5906.
36. Salvador LM, Mukherjee S, Kahn RA, et al. Activation of the luteinizing hormone/choriogonadotropin hormone receptor promotes ADP ribosylation factor 6 activation in porcine ovarian follicular membranes. J Biol Chem. 2001;276:33773-33781.
37. Breen SM, Andric N, Ping T, et al. Ovulation involves the luteinizing hormone-dependent activation of G(q/11) in granulosa cells. Mol Endocrinol. 2013;27:1483-1491.
38. Galet C, Ascoli M. Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells. Cell Signal. 2008;20:1822-1829.
39. Evaul K, Hammes SR. Cross-talk between G protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells. J Biol Chem. 2008;283: 27525-27533.
40. Tranchant T, Durand G, Gauthier C, et al. Preferential β arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation. Mol Cell Endocrinol. 2011;331:109-118.
41. Grotegut CA, Feng L, Mao L, Heine RP, Murtha AP, Rockman HA. β Arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration. Am J Physiol Endocrinol Metab. 2011;300:E468-E477.
42. Brighton PJ, Rana S, Challiss RJ, Konje JC, Willets JM. Arrestins differentially regulate histamine-and oxytocin-evoked phospho-lipase C and mitogen-activated protein kinase signalling in myometrial cells. Br J Pharmacol. 2011;162:1603-1617.
43. Terzidou V, Blanks AM, Kim SH, Thornton S, Bennett PR. Labor and inflammation increase the expression of oxytocin receptor in human amnion. Biol Reprod. 2011;84:546-552.
44. Kim SH, MacIntyre DA, Firmino Da Silva M, et al. Oxytocin activates NF-B-mediated inflammatory pathways in human gestational tissues. Mol Cell Endocrinol. 2015;403:64-77.
45. Ahow M, Min L, Pampillo M, et al. KISS1R signals independently of G q/11 and triggers LH secretion via the β arrestin pathway in the male mouse. Endocrinology. 2014;155:4433-4446.
46. Pike LJ. Lipid rafts: bringing order to chaos. J Lipid Res. 2003; 44:655-667.
47. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46-50.
48. Hiol A, Davey PC, Osterhout JL, et al. Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function. I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. J Biol Chem. 2003;278:19301-19308.
49. Monastyrskaya K, Hostettler A, Buergi S, Draeger A. The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J Biol Chem. 2005; 280:7135-7146
50. Pucadyil TJ, Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin (1A) receptors from bovine hippocampus. Biochim Biophys Acta. 2004;1663:188-200.
51. Navratil AM, Bliss SP, Berghorn KA, et al. Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. J Biol Chem. 2003;278:31593-31602.
52. Bliss SP, Navratil AM, Breed M, Skinner DC, Clay CM, Roberson MS. Signaling complexes associated with the type I gonadotropin-releasing hormone (GnRH) receptor: colocalization of extracellu-larly regulated kinase 2 and GnRH receptor within membrane rafts. Mol Endocrinol. 2007;21:538-549.
53. Navratil AM, Farmerie TA, Bogerd J, Nett TM, Clay CM. Differential impact of intracellular carboxyl terminal domains on lipid raft localization of the murine gonadotropin-releasing hormone receptor. Biol Reprod. 2006;74:788-797.
54. Navratil AM, Bliss SP, Roberson MS. Membrane rafts and GnRH receptor signaling. Brain Res. 2010;1364:53-61.
55. Lei Y, Hagen GM, Smith SM, Barisas BG, Roess DA. Chimeric GnRH-LH receptors and LH receptors lacking C-terminus palmitoylation sites do not localize to plasma membrane rafts. Biochem Biophys Res Commun. 2005;337:430-434.
56. Wolf-Ringwall AL, Winter PW, Roess DA, George Barisas B. Luteinizing hormone receptors are confined in mesoscale plasma membrane microdomains throughout recovery from receptor de-sensitization. Cell Biochem Biophys. 2014;68:561-569.
57. Wolf-Ringwall AL, Winter PW, Liu J, Van Orden AK, Roess DA, Barisas BG. Restricted lateral diffusion of luteinizing hormone receptors in membrane microdomains. J Biol Chem. 2011;286: 29818-29827.
58. Dang AK, Murtazina DA, Magee C, Navratil AM, Clay CM, Amberg GC. GnRH evokes localized subplasmalemmal calcium signaling in gonadotropes. Mol Endocrinol. 2014;28:2049-2059.
59. Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ. GnRH activates ERK1/2 leading to the induction of c-fos and LH β protein expression in LβT2 cells. Mol Endocrinol. 2002;16:419-434.
60. Wehmeyer L, Du Toit A, Lang DM, Hapgood JP. Lipid raft-and protein kinase C-mediated synergism between glucocorticoid-and gonadotropin-releasing hormone signaling results in decreased cell proliferation. J Biol Chem. 2014;289:10235-10251.
61. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14:367-378.
62. Perrett RM, Voliotis M, Armstrong SP, et al. Pulsatile hormonal signaling to extracellular signal-regulated kinase: exploring system sensitivity to gonadotropin-releasing hormone pulse frequency and width. J Biol Chem. 2014;289:7873-7883.
63. Pike LJ. The challenge of lipid rafts. J Lipid Res. 2009;50(suppl): S323-S328.
64. Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996;271: 15160-15165.
65. Shvets E, Ludwig A, Nichols BJ. News from the caves: update on the structure and function of caveolae. Curr Opin Cell Biol. 2014; 29:99-106.
66. Oh P, Schnitzer JE. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell. 2001;12:685-698.
67. Chini B, Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol. 2004;32:325-338
68. Sengupta P, Philip F, Scarlata S. Caveolin-1 alters Ca(2) signal duration through specific interaction with the G q family of G proteins. J Cell Sci. 2008;121:1363-1372.
69. Whittington K, Connors B, King K, Assinder S, Hogarth K, Nicholson H. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate. 2007;67:1132-1142.
70. Marchese A, Paing MM, Temple BR, Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol. 2008;48:601-629.
71. Yudowski GA, Puthenveedu MA, Henry AG, von Zastrow M. Cargo-mediated regulation of a rapid Rab4-dependent recycling pathway. Mol Biol Cell. 2009;20:2774-2784.
72. Seachrist JL, Anborgh PH, Ferguson SS. β2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem. 2000;275: 27221-27228.
73. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the ÷2-adrenergic receptor. Nature. 1999;401:286-290.
74. Lauffer BE, Melero C, Temkin P, et al. SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane. J Cell Biol. 2010;190:565-574.
75. Yudowski GA, Puthenveedu MA, von Zastrow M. Distinct modes of regulated receptor insertion to the somatodendritic plasma membrane. Nat Neurosci. 2006;9:622-627.
76. Yu YJ, Dhavan R, Chevalier MW, Yudowski GA, von Zastrow M. Rapid delivery of internalized signaling receptors to the somato-dendritic surface by sequence-specific local insertion. J Neurosci. 2010;30:11703-11714.
77. Jullié D, Choquet D, Perrais D. Recycling endosomes undergo rapid closure of a fusion pore on exocytosis in neuronal dendrites. J Neurosci. 2014;34:11106-11118.
78. Wong W, Scott JD. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol. 2004;5:959-970.
79. Logue JS, Scott JD. Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J. 2010;277:4370-4375.
80. Tao J, Shumay E, McLaughlin S, Wang HY, Malbon CC. Regulation of AKAP-membrane interactions by calcium. J Biol Chem. 2006;281:23932-23944.
81. Shih M, Lin F, Scott JD, Wang HY, Malbon CC. Dynamic complexes of ÷2-adrenergic receptors with protein kinases and phos-phatases and the role of gravin. J Biol Chem. 1999;274:1588-1595.
82. Tao J, Malbon CC. G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal. 2008;3:19.
83. El-Jouni W, Haun S, Hodeify R, Hosein Walker A, Machaca K. Vesicular traffic at the cell membrane regulates oocyte meiotic arrest. Development. 2007;134:3307-3315.
84. Nishimura T, Fujii W, Sugiura K, Naito K. Cytoplasmic anchoring of cAMP-dependent protein kinase (PKA) by A-kinase anchor proteins (AKAPs) is required for meiotic arrest of porcine full-grown and growing oocytes. Biol Reprod. 2014;90:58.
85. Hinckley M, Vaccari S, Horner K, Chen R, Conti M. The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. Dev Biol. 2005;287:249-261.
86. Calebiro D, Nikolaev VO, Gagliani MC, et al. Persistent cAMP signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 2009;7:e1000172.
87. Ferrandon S, Feinstein TN, Castro M, et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol. 2009;5:734-742.
88. Feinstein TN, Wehbi VL, Ardura JA, et al. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol. 2011;7:278-284.
89. Gidon A, Al-Bataineh MM, Jean-Alphonse FG, et al. Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase. Nat Chem Biol. 2014;10:707-709.
90. Okazaki M, Ferrandon S, Vilardaga JP, Bouxsein ML, Potts JT Jr, Gardella TJ. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci USA. 2008;105:16525-16530.
91. Irannejad R, Tomshine JC, Tomshine JR, et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature. 2013;495:534-538.
92. Rasmussen SG, Choi HJ, Fung JJ, et al. Structure of a nanobody-stabilized active state of the ÷(2) adrenoceptor. Nature. 2011;469: 175-180.
93. Tsvetanova NG, von Zastrow M. Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis. Nat Chem Biol. 2014; 10:1061-1065.
94. Kuna RS, Girada SB, Asalla S, et al. Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β cells. Am J Physiol Endocrinol Metab. 2013;305:E161-E170.
95. Merriam LA, Baran CN, Girard BM, Hardwick JC, May V, Parsons RL. Pituitary adenylate cyclase 1 receptor internalization and endosomal signaling mediate the pituitary adenylate cyclase activating polypeptide-induced increase in guinea pig cardiac neuron excitability. J Neurosci. 2013;33:4614-4622.
96. Feinstein TN, Yui N, Webber MJ, et al. Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J Biol Chem. 2013;288:27849-27860.
97. Hoshino T, Namba T, Takehara M, et al. Prostaglandin E2 stimulates the production of amyloid-β peptides through internalization of the EP4 receptor. J Biol Chem. 2009;284:18493-18502.
98. Min L, Soltis K, Reis AC, et al. Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling. Mol En-docrinol. 2014;28:16-27.
99. Bianco SD, Vandepas L, Correa-Medina M, et al. KISS1R intracellular trafficking and degradation: effect of the Arg386Pro disease-associated mutation. Endocrinology. 2011;152:1616-1626
100. Galet C, Hirakawa T, Ascoli M. The postendocytotic trafficking of the human lutropin receptor is mediated by a transferable motif consisting of the C-terminal cysteine and an upstream leucine. Mol Endocrinol. 2004;18:434-446.
101. Jean-Alphonse F, Bowersox S, Chen S, Beard G, Puthenveedu MA, Hanyaloglu AC. Spatially restricted G protein-coupled receptor activity via divergent endocytic compartments. J Biol Chem. 2014;289:3960-3977.
102. Miaczynska M, Christoforidis S, Giner A, et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell. 2004;116:445-456.
103. Hirakawa T, Galet C, Kishi M, Ascoli M. GIPC binds to the human lutropin receptor (hLHR) through an unusual PDZ domain binding motif, and it regulates the sorting of the internalized human choriogonadotropin and the density of cell surface hLHR. J Biol Chem. 2003;278:49348-49357.
104. Koliwer J, Park M, Bauch C, von Zastrow M, Kreienkamp HJ. The Golgi-associated PDZ domain protein PIST/GOPC stabilizes the β1-adrenergic receptor in intracellular compartments after in-ternalization. J Biol Chem. 2015;290(10):6120-6129.
105. Lin DC, Quevedo C, Brewer NE, et al. APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol Cell Biol. 2006;26:8928-8941.
106. Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol. 2006;8:516-523.
107. Schenck A, Goto-Silva L, Collinet C, et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell. 2008;133:486-497.
108. Varsano T, Dong MQ, Niesman I, et al. GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol Cell Biol. 2006;26:8942-8952.
109. Zoncu R, Perera RM, Balkin DM, Pirruccello M, Toomre D, De Camilli P. A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell. 2009;136:1110-1121.
110. Casarini L, Lispi M, Longobardi S, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One. 2012;7:e46682
111. Nelson VL, Legro RS, Strauss JF 3rd, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 1999; 13:946-957
112. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 1994;79:1158-1165.
113. Hu LA, Chen W, Martin NP, Whalen EJ, Premont RT, Lefkowitz RJ. GIPC interacts with the ÷1-adrenergic receptor and regulates β1-adrenergic receptor-mediated ERK activation. J Biol Chem. 2003;278:26295-26301.
114. Dias JA, Mahale SD, Nechamen CA, Davydenko O, Thomas RM, Ulloa-Aguirre A. Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3 interaction domain with a canonical G-protein interaction site. Mol Cell Endocrinol. 2010;329:17-25.
115. Berning S, Willig KI, Steffens H, Dibaj P, Hell SW. Nanoscopy in a living mouse brain. Science. 2012;335:551.
116. Khoury E, Clement S, Laporte SA. Allosteric and biased g protein-coupled receptor signaling regulation: potentials for new thera-peutics. Front Endocrinol (Lausanne). 2014;5:68.
117. Violin JD, Crombie AL, Soergel DG, Lark MW. Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci. 2014;35:308-316.
118. Carr R, Du Y, Quoyer J, et al. Development and characterization of pepducins as Gs-biased allosteric agonists. J Biol Chem. 2014;289:35668-35684.
119. Quoyer J, Janz JM, Luo J, et al. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein. Proc Natl Acad Sci USA. 2013; 110:E5088-E5097.
120. Staus DP, Wingler LM, Strachan RT, et al. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies. Mol Pharmacol. 2014;85:472-481
121. Shukla AK. Biasing GPCR signaling from inside. Sci Signal. 2014; 7:p e3.
122. Fournier T, Guibourdenche J, Evain-Brion D. Review: hCGs: different sources of production, different glycoforms and functions. Placenta. 2015;36(suppl 1):S60-S65.
123. Jiang C, Hou X, Wang C, et al. Hypoglycosylated hFSH has greater bioactivity than fully glycosylated recombinant hFSH in human granulosa cells. J Clin Endocrinol Metab. 2015;100:E852-E860.
124. Yu HN, Richardson TE, Nataraja S, et al. Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators. Bioorg Med Chem Lett. 2014;24:2168-2172.
125. Heitman LH, Ye K, Oosterom J, Ijzerman AP. Amiloride deriva-tives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor. Mol Pharmacol. 2008;73:1808-1815.
126. Conn PM, Ulloa-Aguirre A, Ito J, Janovick JA. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev. 2007; 59:225-250.